Dr. McCall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 DNA Way
South San Francisco, CA 94080Phone+1 415-846-8056- Is this information wrong?
Education & Training
St Mary's Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2004
University of WashingtonResidency, Anesthesiology, 1989 - 1993
University of California San Diego School of MedicineClass of 1989
Publications & Presentations
PubMed
- 13 citationsPhase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumorsColin D. Weekes, Lee S. Rosen, Anna Capasso, Kit Man Wong, Weilan Ye, Maria Anderson, Bruce McCall, Jill Fredrickson, Eric Wakshull, Steve Eppler, Quyen Shon-Nguyen, R...> ;Cancer Chemotherapy and Pharmacology. 2018 Jun 15
- 36 citationsPhase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorecta...Andrew G. Hill, Michael Findlay, Matthew Burge, Christopher Jackson, Pilar García Alfonso, Leslie Samuel, Vinod Ganju, M. Karthaus, Alessio Amatu, Mark Jeffery, Maria ...> ;Clinical Cancer Research. 2018 May 15
- 27 citationsPhase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5‐fluorouracil or carboplatin/paclitaxel for first‐line treatment of recurrent/metastatic squamous cell carc...Antonio Jimeno, Jean-Pascal Machiels, Lori J. Wirth, Pol Specenier, Tanguy Y. Seiwert, Feby Mardjuadi, X. Wang, Amy V. Kapp, Stephanie Royer-Joo, Elicia Penuel, Bruce ...> ;Cancer. 2016 Dec 15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
